LOTIS 2 FOLLOW‐UP ANALYSIS: UPDATED RESULTS FROM A PHASE 2 STUDY OF LONCASTUXIMAB TESIRINE IN RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA

Journal article

Peer reviewed

P. L. Zinzani, P. F. Caimi, C. Carlo‐Stella, W. Ai, J. P. Alderuccio, K. M. Ardeshna, B. Hess, B. S. Kahl, J. Radford, M. Solh, …

Hematological oncology, Vol.39(S2)

2021-06

Metrics

11 Record Views

Title: LOTIS 2 FOLLOW‐UP ANALYSIS: UPDATED RESULTS FROM A PHASE 2 STUDY OF LONCASTUXIMAB TESIRINE IN RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA
Creators: P. L. Zinzani - Medicina
P. F. Caimi - University Hospitals of Cleveland
C. Carlo‐Stella - Humanitas University
W. Ai - University of California, San Francisco
J. P. Alderuccio - Sylvester Comprehensive Cancer Center
K. M. Ardeshna - University College London Hospitals NHS Foundation Trust
B. Hess - Medical University of South Carolina
B. S. Kahl - Washington University in St. Louis
J. Radford - The Christie NHS Foundation Trust
M. Solh - Northside Hospital
A. Stathis - Institute of Oncology Research
J. Feingold - Adc Therapeutics
D. Ungar - Adc Therapeutics
Y. Qin - Adc Therapeutics
S. He - Adc Therapeutics
M. Hamadani - Medical College of Wisconsin
Publication Details: Hematological oncology, Vol.39(S2)
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031713948202976